Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. June 13, 2018. Nikolai Aljuri.

Executive Summary

Procept BioRobotics is seeking a unique Category I CPT code that would make it possible for its AquaBeam Aquablation device to be reimbursed at a higher rate than older prostate resection techniques. See what company founder and CEO Nikolai Aljuri said about it here.

"We decided to go with our own code because we knew that showing a benefit over the existing procedures would put us in a great position to have a better payment than all the existing technologies. That's something companies don't do; they just want to fit into an existing code, but once you do that you get boxed into a certain kind of payment. Here, given that we provide so many benefits, we were very confident that we should have our own code with a greater payment." –Nikolai Aljuri, CEO, Procept BioRobotics

Click here for a free trial of Medtech Insight


Related Content

Procept BioRobotics Believes Aquablation Could Dominate BPH Treatment…If It Gets Coverage





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts